Polyvalent Melanoma Vaccine Improves Survival of Patients with Metastatic Melanomaa
Data up to Jan 2025
Total Citations Per Year
Abstract
References (49)
A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma
1991 • 3,493 citations
Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic Melanoma
1988 • 2,196 citations
Experience with the Use of High-Dose Interleukin-2 in the Treatment of 652 Cancer Patients
1989 • 1,003 citations
Biologic Therapy of Cancer
1992 • 476 citations
Immunological factors which influence response to immunotherapy in malignant melanoma.
1970 • 462 citations
BCG lmmunotherapy of Malignant Melanoma
1974 • 430 citations
Prolongation of Survival in Metastatic Melanoma After Active Specific Immunotherapy With a New Polyvalent Melanoma Vaccine
1992 • 410 citations
Demonstration of antibodies against human malignant melanoma by immunofluorescence.
1968 • 390 citations
A multifactorial analysis of melanoma. IV. Prognostic factors in 200 melanoma patients with distant metastases (stage III).
1983 • 360 citations
Identification of a human neuroectodermal tumor antigen (OFA-I-2) as ganglioside GD2.
1982 • 242 citations
Active specific immunotherapy for melanoma: phase I trial of allogeneic lysates and a novel adjuvant.
1988 • 239 citations
Vaccines containing purified GM2 ganglioside elicit GM2 antibodies in melanoma patients.
1987 • 224 citations
A monoclonal antibody recognizes an O-acylated sialic acid in a human melanoma-associated ganglioside.
1984 • 222 citations
Complications of BCG Immunotherapy in Patients with Cancer
1973 • 215 citations
Ganglioside GM2 as a human tumor antigen (OFA-I-1).
1983 • 174 citations
Prospectively randomized trial of adjuvant active‐specific immunotherapy for human colorectal cancer
1985 • 164 citations
Phase I trial of a mouse monoclonal antibody against GD3 ganglioside in patients with melanoma: induction of inflammatory responses at tumor sites.
1988 • 153 citations
Prospectively randomized trial of adjuvant active-specific immunotherapy for human colorectal cancer
1985 • 149 citations
Surgical Resection and Adjunctive lmmunotherapy for Selected Patients with Multiple Pulmonary Metastases
1973 • 142 citations
Prolonged Survival for Melanoma Patients With Elevated IgM Antibody to Oncofetal Antigen<xref ref-type="fn" rid="fn2">2</xref><xref ref-type="fn" rid="fn3">3</xref>
1981 • 126 citations
Complete responses and long-term survivals after systemic chemotherapy for patients with advanced malignant melanoma
1989 • 105 citations
Gangliosides and cancer
1989 • 85 citations
Modulation of human melanoma cells by interleukin-4 and in combination with gamma-interferon or alpha-tumor necrosis factor.
1991 • 76 citations
Immunization with haptenized, autologous tumor cells induces inflammation of human melanoma metastases.
1991 • 76 citations
Suppressor cell activity in a randomized trial of patients receiving active specific immunotherapy with melanoma cell vaccine and low dosages of cyclophosphamide.
1990 • 75 citations
An epitope common to gangliosides O-acetyl-GD3 and GD3 recognized by antibodies in melanoma patients after active specific immunotherapy.
1989 • 67 citations
A southeastern cancer study group phase I/II trial with vaccinia melanoma oncolysates
1986 • 65 citations
Interleukin 4 alone and with gamma-interferon or alpha-tumor necrosis factor inhibits cell growth and modulates cell surface antigens on human renal cell carcinomas.
1991 • 64 citations
Immunogenicity of a polyvalent melanoma antigen vaccine in humans
1988 • 62 citations
Combination tumor‐immunotherapy with recombinant tumor necrosis factor and recombinant interleukin 2 in mice
1987 • 57 citations
PRELIMINARY RESULTS OF A RANDOMIZED TRIAL OF ADJUVANT IMMUNOTHERAPY IN PATIENTS WITH MALIGNANT MELANOMA WHO HAVE LYMPH NODE METASTASES
1978 • 45 citations
Anti-Idiotype Monoclonal Antibody Carrying the Internal Image of Ganglioside GM3
1990 • 44 citations
Induction of antibodies to a tumor-associated antigen by immunization with a whole melanoma cell vaccine
1989 • 44 citations
Active specific immunotherapy in malignant melanoma
1989 • 41 citations
Active immunotherapy against cancer: present status.
1986 • 39 citations
Human monoclonal antibody against ganglioside GD2: use in development of enzyme-linked immunosorbent assay for the monitoring of anti-GD2 in cancer patients.
1984 • 38 citations
Active specific immunotherapy with vaccinia colon oncolysate enhances the immunomodulatory and antitumor effects of interleukin-2 and interferon α in a murine hepatic metastasis model
1990 • 30 citations
Induction of CD4+ cytotoxic T cells by sensitization with allogeneic melanomas bearing shared or cross-reactive HLA-A
1992 • 28 citations
Role of Gangliosides in Active Immunotherapy with Melanoma Vaccine
1991 • 28 citations
Effect of continuous administration of interleukin 2 on active specific chemoimmunotherapy with extracted tumor-specific transplantation antigen and cyclophosphamide.
1988 • 27 citations
Immunochemical characterization of fetal antigen isolated from spent medium of a human melanoma cell line.
1983 • 27 citations
Modulation of Histamine Type II Receptors on CD8+ T Cells by lnterleukin-2 and Cimetidine
1992 • 24 citations
Production and characterization of a murine/human chimeric anti-idiotype antibody that mimics ganglioside.
1992 • 19 citations
Studies of a Melanoma Tumor-Associated Antigen Detected in the Spent Culture Medium of a Human Melanoma Cell Line by Allogeneic Antibody. I. Purification and Development of a Radioimmunoassay23
1984 • 19 citations
Cytotoxic T cell lines recognize autologous and allogeneic melanomas with shared or cross-reactive HLA-A
1992 • 17 citations
Human Tumor Antigens and Specific Tumor Therapy
1990 • 14 citations
Humoral immune response to melanoma-associated membrane antigen and fetal brain antigen demonstrated by indirect membrane immunofluorescence. I
1979 • 13 citations
Rejection of dinitrochlorobenzene-conjugated syngeneic tumor cells by dinitrochlorobenzene-sensitized guinea pigs
1978 • 7 citations
Deleted Work
1955 • 0 citations
Cited By (0)
No citing papers found in database